NCT05020678 2026-04-20NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell CancersNkarta, Inc.Phase 1 Active not recruiting150 enrolled
NCT05563844 2026-02-04Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)Chengdu Zenitar Biomedical Technology Co., LtdPhase 2 Active not recruiting74 enrolled